Biologic markers in cancer diagnosis and treatment (Q40316254)

19 September 2017

1 reference

title

Biologic markers in cancer diagnosis and treatment (English)

1 reference

19 September 2017

1 reference

Holyoke ED

1

1 reference

19 September 2017

Block GE

2

1 reference

19 September 2017

Jensen E

3

1 reference

19 September 2017

Sizemore GW

4

1 reference

19 September 2017

Heath H

5

1 reference

19 September 2017

Chu TM

6

1 reference

19 September 2017

Murphy GP

7

1 reference

19 September 2017

Mittelman A

8

1 reference

19 September 2017

Ruddon RW

9

1 reference

19 September 2017

Arnott MS

10

1 reference

19 September 2017

publication date

1 August 1981

1 reference

Current Problems in Cancer

19 September 2017

published in

1 reference

19 September 2017

volume

6

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

1-68

1 reference

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Estrogen-receptor interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

The uptake of tritiated oestradiol by dimethylbenzanthracene-induced mammary tumours of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Hormone dependency in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Clinical relevance of steroid-receptor measurements in tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

The Prediction of Hormonal Dependency of Mammary Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Current status of estrogen receptors in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Estrogen and estrogen receptors of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Estrogen Receptor and Natural Course of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Antiestrogens in treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Correlation of estrophilin content of primary mammary cancer to eventual endocrine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Current status of estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

The association of pheochromocytoma with carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

C-Cell Hyperplasia Preceding Medullary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Adrenal medullary disease in multiple endocrine neoplasia, type 2: pheochromocytoma and its precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Preoperative diagnosis of occult parathyroid hyperplasia by calcium infusion in patients with multiple endocrine neoplasia, type 2a

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Medullary carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Calcitonin Production and the Mitochondrion-Rich Cells of the Dog Thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Immunoassay of Human Calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Early Diagnosis of Medullary Carcinoma of the Thyroid Gland by Means of Calcitonin Assay

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Detection of medullary thyroid cancer by calcitonin assay in families

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Epidemiology of medullary carcinoma of the thyroid gland: a 5-year experience (1971-1976)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Relations of Calcitonin and Gastrin in the Zollinger-Ellison Syndrome and Medullary Carcinoma of the Thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Plasma calcitonin in normal man. Differences between men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Multiple immunoreactive forms of calcitonin in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Immunochemical Heterogeneity of Calcitonin in Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in 2 patients with medullary carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

A short calcium infusion in the diagnosis of medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Plasma human calcitonin (hCT) levels in normal and pathologic conditions, and their responses to short calcium or tetragastrin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Alcohol-stimulated calcitonin release in medullary carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Stimulation of thyrocalcitonin secretion by ethanol in patients with medullary thyroid carcinoma—An effect apparently not mediated by gastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Whisky: a new provacative test for calcitonin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Pentagastrin test and calcitonin heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Ectopic secretion of calcitonin by oat-cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Secretion of immunoreactive calcitonin by human breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Hypercalcitonemia in bronchogenic cancer. Evidence for thyroid origin of the hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Prospective evaluation of some candidate tumor markers in the diagnosis of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Multiple endocrine neoplasia type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Clinical application of phosphohydrolase measurements in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Clinical significance of the human acid phosphatases: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

A Solid Phase Radioimmunoassay for Prostatic Acid Phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Human prostatic acid phosphatases: II. A double--antibody radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Human prostatic acid phosphatases: I. Isolation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Bone marrow acid phosphatase by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Human prostatic acid phosphatases: III. Counterimmunoelectrophoresis for rapid identification

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Counter immunoelectrophoresis for detection of human prostatic acid phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Usefulness of bone marrow serum acid phosphatase in staging carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Bone marrow acid phosphatase: another look

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Lack of usefulness of bone marrow enzymes and calcium in staging patients with prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

A solid-phase immunoadsorbent assay for serum prostatic acid phosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

A radioimmune assay for human prostatic acid phosphatase-levels in prostatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Value of new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Prostatic origin of tumors. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Foetal "antigens" in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Sulphoglycoprotein antigens in the human alimentary canal and gastric cancer. An immunohistological study

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

The development of a double-antibody radioimmunoassay for detecting ovarian tumor-associated antigen fraction OCA in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Tumor antigen of human cervical squamous cell carcinoma.Correlation of circulating levels with disease progress

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique. II. Nature of tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

New oncofetal antigen for human pancreas.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

The prospective evaluation of tumour-associated antigens for the early diagnosis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Immunologic studies on a pancreatic oncofetal protein

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Tumor-Associated Antigen Levels (Carcinoembryonic Antigen, Human Chorionic Gonadotropin, and Alpha-Fetoprotein) Antedating the Diagnosis of Cancer in the Framingham Study 1

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Carcinoembryonic Antigen Assay of Ascites and Detection of Malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

The possible role of the carcinoembryonic antigen (CEA) and other carcinofetal antigens in maligant and benign diseases of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

The CEA concentration in duodenal fluid in patients with pancreatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Roole of carcinoembryonic antigen in bronchial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Initial levels of CEA and their rate of change in pancreatic carcinoma following surgery chemotherapy and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

CEA levels in patients with carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Preoperative carcinoembryonic antigen levels in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Serial CEA levels in colorectal carcinoma on adjuvant immuno (chemo) therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Carcinoembryonic Antigen andβ2-Microglobulin as Serum Tumor Markers in Women with Genital Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Tissue CEA in premalignant epithelial lesions and epidermoid carcinoma of the uterine cervix: Prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Clinical value of carcinoembryonic antigen: diagnosis, prognosis, and follow-up of patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Carcinoembryonic antigen (CEA): its role as a monitor of radiation therapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

A retrospective and prospective study of serial CEA determinations in the early detection of recurrent colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Carcinoembryonic antigen, alpha 1-fetoprotein, ferritin, and alpha 2-pregnancy associated glycoprotein in the serum of lung cancer patients and its demonstration in lung tumor tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detection

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.).

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Casein and other tumor markers in relation to cancer of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

A quantitative approach to determining disease response during therapy using multiple biologic markers.Application to carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Usefulness of serial serum carcinoembryonic antigen (CEA) determinations during anticancer therapy or long-term follow-up of gastrointestinal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Carcinoembryonic antigen (CEA) and other tumor markers in ovarian and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Carcinoembryonic antigen (CEA) in gastric juice or feces as an aid in the diagnosis of gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Immunoreactive carcinoembryonic antigen [CEA] levels in feces from colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Fibrinolytic activity of human tumors as measured by the fibrin-plate method

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Fibrinolysis associated with human neoplasia: production of plasminogen activator by human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Relationship Between Fibrinolysis of Cultured Cells and Malignancy2

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Ovarian plasminogen activator: Relationship to ovulation and hormonal regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Immunosuppression by micromolecular fibrinogen degradation products in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Urinary excretion of the cancer-related glycoprotein EDCl: effect of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Unique human glycoprotein, 7alpha;1-microglycoprotein: isolation from the urine of a cancer patient and its characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Purification and identification of a human-serum DNA-binding protein associated with malignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

A correlation of serum C3DP levels with chemotherapeutic management of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Arene oxides: a new aspect of drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Chemical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

The genetics of aryl hydrocarbon hydroxylase induction in mice: A single gene difference between C57BL/6J and DBA/2J

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Genetics of aryl hydrocarbon hydroxylase induction in mice: additive inheritance in crosses between C3H-HeJ and DBA-2J

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse. Distinction between the "responsive" homozygote and heterozygote at the Ah locus

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Aryl Hydrocarbon Hydroxylase Induction in Human Leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Metabolism of polycyclic aromatic hydrocarbons in cultured human leukocytes under genetic control

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Mitogenic Effect of Phytohaemagglutinin at Different Ages

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

Abnormal lymphocyte protein synthesis in bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2881%2980007-4

7 January 2021

10.1016/S0147-0272(81)80007-4

Identifiers

DOI

1 reference

19 September 2017

1 reference